VYM vs XLV
Vanguard High Dividend Yield ETF vs Health Care Select Sector SPDR Fund
- • VYM has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • VYM pays a higher dividend yield (2.24%).
Side-by-side metrics
| Metric | VYM | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 2.24% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $94.63B | $37.88B |
YTD return | 10.01% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.73 | 0.58 |
P/E ratio | 21.57 | 26.68 |
Last price | $155.16 | $144.72 |
Inception | — | — |
Issuer | Vanguard | State Street |
VYM top holdings
| AVGO | Broadcom Inc | 6.28% |
| JPM | JPMorgan Chase & Co | 3.27% |
| XOM | Exxon Mobil Corp | 3.15% |
| JNJ | Johnson & Johnson | 2.58% |
| CVX | Chevron Corp | 1.70% |
| ABBV | AbbVie Inc | 1.69% |
| PG | Procter & Gamble Co | 1.49% |
| CAT | Caterpillar Inc | 1.44% |
| HD | The Home Depot Inc | 1.44% |
| CSCO | Cisco Systems Inc | 1.36% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About VYM
VYM (Vanguard High Dividend Yield ETF) is US large-caps with above-average dividend yields. Managed by Vanguard, the fund carries $94.6B in assets under management, an expense ratio of 0.04%, a dividend yield of 2.24%. Its largest holding is Broadcom Inc (AVGO), which represents 6.3% of the portfolio. Real Estate is the fund's largest sector exposure at 0.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.